Related references
Note: Only part of the references are listed.The Argument for Mitotic Rate-based Grading for the Prognostication of Adrenocortical Carcinoma
Thomas J. Giordano
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
Sebastien Gaujoux et al.
CLINICAL CANCER RESEARCH (2011)
Oncocytic adrenocortical neoplasms - a clinicopathologic study of 13 new cases emphasizing the importance of their recognition
Daniel D. Wong et al.
HUMAN PATHOLOGY (2011)
Genetics and genomics of childhood adrenocortical tumors
Abeer El Wakil et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Adrenocortical Tumors With Myxoid Features: A Distinct Morphologic and Phenotypical Variant Exhibiting Malignant Behavior
Mauro Papotti et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Classification of adrenal cortical tumors: What limits for the pathological approach?
Frederique Tissier
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
Bruno Ragazzon et al.
CANCER RESEARCH (2010)
High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors
Silviu Sbiera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade
Barbra S. Miller et al.
LANGENBECKS ARCHIVES OF SURGERY (2010)
Sarcomatoid carcinoma of the adrenal gland: A case report and review of literature
Antonella Coli et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Clinical management of adrenocortical carcinoma
Martin Fassnacht et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas
Martin Fassnacht et al.
CANCER (2009)
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Thomas J. Giordano et al.
CLINICAL CANCER RESEARCH (2009)
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma
Wiebke Fenske et al.
ENDOCRINE-RELATED CANCER (2009)
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
Marco Volante et al.
HISTOPATHOLOGY (2009)
The Weiss system for evaluating adrenocortical neoplasms: 25 years later
Sean K. Lau et al.
HUMAN PATHOLOGY (2009)
Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 Labeling index is a predictor for recurrence of adrenocortical carcinomas
Ryo Morimoto et al.
ENDOCRINE JOURNAL (2008)
Pathological and molecular features of adrenocortical carcinoma: an update
M. Volante et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Primary adrenocortical sarcomatoid carcinoma:: Case report and review of literature
Nathalie Sturm et al.
VIRCHOWS ARCHIV (2008)
The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas
H. P. van't Sant et al.
HISTOPATHOLOGY (2007)
Histologic criteria for adrenocortical proliferative lesions - Value of mitotic figure variability
Alfredo Blanes et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity
Rossella Libe et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic parameters of metastatic adrenocortical carcinoma
Guillaume Assie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adrenocortical cancer: pathophysiology and clinical management
Rossella Libe et al.
ENDOCRINE-RELATED CANCER (2007)
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas
Marco Volante et al.
MODERN PATHOLOGY (2006)
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours
A. Schmitt et al.
HISTOPATHOLOGY (2006)
Adrenocortical oncocytic tumors: Report of 10 cases and review of the literature
M Bisceglia et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2004)
Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors
F Tissier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Adrenocortical adenoma and carcinoma: Histopathological and molecular comparative analysis
A Stojadinovic et al.
MODERN PATHOLOGY (2003)
Adrenal cortical neoplasms in the pediatric population - A clinicopathologic and immunophenotypic analysis of 83 patients
JA Wieneke et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Weiss system revisited - A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors
S Aubert et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
M Terzolo et al.
UROLOGY (2001)
Pediatric adrenocortical tumors:: Molecular events leading to insulin-like growth factor II gene overexpression
F Wilkin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
High expression of cyclin E and G1 CDK and loss of function of p57(KIP2) are involved in proliferation of malignant sporadic adrenocortical tumors
N Bourcigaux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
